z-logo
open-access-imgOpen Access
Hepatocellular carcinoma, novel therapies on the horizon
Author(s) -
Imane El Dika,
Iman Makki,
Ghassan K. AbouAlfa
Publication year - 2020
Publication title -
chinese clinical oncology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.733
H-Index - 22
eISSN - 2304-3873
pISSN - 2304-3865
DOI - 10.21037/cco-20-113
Subject(s) - medicine , lenvatinib , sorafenib , regorafenib , nivolumab , ramucirumab , bevacizumab , pembrolizumab , hepatocellular carcinoma , oncology , cabozantinib , disease , cancer , chemotherapy , immunotherapy , colorectal cancer

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom